Norges Bank’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $232M | Buy |
+1,548,518
| New | +$168M | 0.02% | 492 |
|
|
2026
Q1 | – | Sell |
-1,258,072
| Closed | -$128M | – | 561 |
|
|
2025
Q4 | $128M | Buy |
+1,258,072
| New | +$113M | 0.01% | 656 |
|
|
2025
Q3 | – | Sell |
-1,232,428
| Closed | -$64.1M | – | 628 |
|
|
2025
Q2 | $64.1M | Buy |
1,232,428
+19,662
| +2% | +$878K | 0.01% | 856 |
|
|
2025
Q1 | $51.7M | Buy |
1,212,766
+20,024
| +2% | +$864K | 0.01% | 923 |
|
|
2024
Q4 | $36.4M | Buy |
1,192,742
+13,241
| +1% | +$372K | ﹤0.01% | 1080 |
|
|
2024
Q3 | $27.1M | Sell |
1,179,501
-204,267
| -15% | -$5.78M | ﹤0.01% | 1173 |
|
|
2024
Q2 | $40M | Buy |
1,383,768
+214,069
| +18% | +$4.98M | 0.01% | 998 |
|
|
2024
Q1 | $24.1M | Buy |
1,169,699
+226,266
| +24% | +$4.85M | ﹤0.01% | 1206 |
|
|
2023
Q4 | $25.5M | Buy |
943,433
+259,147
| +38% | +$6.8M | ﹤0.01% | 1199 |
|
|
2023
Q3 | $20.3M | Sell |
684,286
-82,381
| -11% | -$2.9M | ﹤0.01% | 1229 |
|
|
2023
Q2 | $27.4M | Sell |
766,667
-278,568
| -27% | -$8M | 0.01% | 1118 |
|
|
2023
Q1 | $24.5M | Buy |
1,045,235
+258,192
| +33% | +$7.37M | 0.01% | 1194 |
|
|
2022
Q4 | $21.4M | Buy |
787,043
+3,200
| +0.4% | +$146K | 0.01% | 1230 |
|
|
2022
Q3 | $42.2M | Sell |
783,843
-8,197
| -1% | -$421K | 0.01% | 841 |
|
|
2022
Q2 | $32M | Buy |
+792,040
| New | +$39.2M | 0.01% | 998 |
|
|
2022
Q1 | – | Sell |
-853,902
| Closed | -$85.4M | – | 2197 |
|
|
2021
Q4 | $85.4M | Buy |
853,902
+69,582
| +9% | +$7.2M | 0.02% | 681 |
|
|
2021
Q3 | $98M | Buy |
784,320
+3,181
| +0.4% | +$378K | 0.02% | 620 |
|
|
2021
Q2 | $97M | Buy |
781,139
+81,941
| +12% | +$11M | 0.02% | 664 |
|
|
2021
Q1 | $107M | Buy |
699,198
+26,996
| +4% | +$4.08M | 0.02% | 615 |
|
|
2020
Q4 | $86.6M | Buy |
672,202
+94,059
| +16% | +$10.8M | 0.02% | 652 |
|
|
2020
Q3 | $64.6M | Sell |
578,143
-9,240
| -2% | -$845K | 0.02% | 722 |
|
|
2020
Q2 | $47.7M | Buy |
587,383
+206,201
| +54% | +$16.6M | 0.01% | 869 |
|
|
2020
Q1 | $26.5M | Hold |
381,182
| – | – | 0.01% | 1065 |
|
|
2019
Q4 | $29.8M | Hold |
381,182
| – | – | 0.01% | 1277 |
|
|
2019
Q3 | $24.3M | Buy |
381,182
+48,361
| +15% | +$4.26M | 0.01% | 1368 |
|
|
2019
Q2 | $28.7M | Buy |
332,821
+292,821
| +732% | +$22.4M | 0.01% | 1256 |
|
|
2019
Q1 | $3.07M | Hold |
40,000
| – | – | ﹤0.01% | 1981 |
|
|
2018
Q4 | $1.5M | Buy |
+40,000
| New | +$1.47M | ﹤0.01% | 2020 |
|
Other funds holding GH
DTC
Norges Bank's GH Position: Q2 2026 in Review
Norges Bank opened a new position in Guardant Health (GH) in Q2 2026: 1,548,518 shares worth $232M. The stake represents 0.02% of the portfolio and ranks #492 among its holdings. This is a return to the name: Norges Bank previously reported a position in GH as recently as Q4 2025.
Norges Bank first reported a position in GH in Q4 2018 and has held it in 28 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Norges Bank held 1,548,518 shares of Guardant Health worth $232M as of Q2 2026.
- Guardant Health was a new Norges Bank position in Q2 2026.
- Guardant Health made up 0.02% of Norges Bank's portfolio in Q2 2026, its #492 holding.
- Norges Bank first reported a position in Guardant Health in Q4 2018 and has held it in 28 quarters since.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.